Esposito, Giuseppe
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation. [electronic resource]
- Gut Aug 2014
- 1300-12 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1468-3288
Standard No.: 10.1136/gutjnl-2013-305005 doi
Subjects--Topical Terms: Amides Anilides--pharmacology Animals Anti-Inflammatory Agents, Non-Steroidal--pharmacology Cells, Cultured Colitis--chemically induced Colitis, Ulcerative--drug therapy Colon, Sigmoid--chemistry Cyclooxygenase 2--metabolism Dextran Sulfate Dinoprostone--metabolism Endocannabinoids--pharmacology Ethanolamines--pharmacology Female Glial Fibrillary Acidic Protein--metabolism Humans Indoles--pharmacology Male Mice Middle Aged NF-kappa B--metabolism Nerve Tissue Proteins--metabolism Neuroglia--drug effects Neutrophil Infiltration--drug effects Nitric Oxide--analysis Nitric Oxide Synthase Type II--metabolism PPAR alpha--antagonists & inhibitors PPAR gamma--antagonists & inhibitors Palmitic Acids--pharmacology Rectum--chemistry S100 Calcium Binding Protein beta Subunit--metabolism Severity of Illness Index Signal Transduction Toll-Like Receptor 4--metabolism Tumor Necrosis Factor-alpha--metabolism